Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells

European Journal of Immunology

Volumn 38, Issue 8, 2008, Pages 2200-2209

  Kistowska, Magdalena ^a   Rossy, Emmanuel ^a   Sansano, Sebastiano ^a   Gober, Hans Jürgen ^a   Landmann, Regine ^a   Mori, Lucia ^a   De Libero, Gennaro ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antigen presentation; Hydroxymethylglutaryl coenzyme A reductase; T cells

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; CARBOXYLYASE; DIPHOSPHOMEVALONATE DECARBOXYLASE; LYMPHOCYTE ANTIGEN RECEPTOR; MEVALONATE KINASE; PHOSPHOMEVALONATE KINASE; PHOSPHOTRANSFERASE;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENZYME ACTIVITY; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; METABOLITE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; BACTERIAL INFECTIONS; CARBOXY-LYASES; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LYMPHOCYTE ACTIVATION; MEVALONIC ACID; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PHOSPHOTRANSFERASES (PHOSPHATE GROUP ACCEPTOR); RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 51149103549     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200838366     Document Type: Article

References (50)

1. Porcelli, S., Brenner, M. B. and Band, H., Biology of the human γδ T-cell receptor. Immunol. Rev. 1991. 120: 137-183.
2. Haas, W., Pereira, P. and Tonegawa, S., γδ cells. Annu. Rev. Immunol. 1993. 11: 637-685.
3. + clones from thymus and peripheral blood. J. Exp. Med. 1989. 170: 1521-1535.
4. Panchamoorthy, G.,McLean, J., Modlin, R. L., Morita, C. T., Ishikawa, S., Brenner, M. B. and Band, H., A predominance of the T cell receptor Vγ2/Vδ2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J. Immunol. 1991. 147: 3360-3369.
5. Davodeau, F., Peyrat, M. A., Hallet, M. M., Houde, I., Vie, H. and Bonneville, M., Peripheral selection of antigen receptor junctional features in a major human cd subset. Eur. J. Immunol. 1993. 23: 804-808.
6. Constant, P., Davodeau, F., Peyrat, M. A., Poquet, Y., Puzo, G., Bonneville, M. and Fournie, J. J., Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994. 264: 267-270.
7. Burk, M. R., Mori, L. and De Libero, G., Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 1995. 25: 2052-2058.
8. Hintz, M., Reichenberg, A., Altincicek, B., Bahr, U., Gschwind, R. M., Kollas, A. K., Beck, E. et al., Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli. FEBS Lett. 2001. 509: 317-322.
9. Tanaka, Y., Morita, C. T., Nieves, E., Brenner, M. B. and Bloom, B. R., Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995. 375: 155-158.
10. Morita, C. T., Lee, H. K., Leslie, D. S., Tanaka, Y., Bukowski, J. F. and Marker-Hermann, E., Recognition of non-peptide prenyl pyrophosphate antigens by human γδ T cells. Microbes Infect. 1999. 1: 175-186.
11. Gober, H. J., Kistowska, M., Angman, L., Jeno, P., Mori, L. and De Libero, G., Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 2003. 197: 163-168.
12. Eberl, M., Hintz, M., Reichenberg, A., Kollas, A. K., Wiesner, J. and Jomaa, H., Microbial isoprenoid biosynthesis and human γδ T cell activation. FEBS Lett. 2003. 544: 4-10.
13. Falini, B., Flenghi, L., Pileri, S., Pelicci, P., Fagioli, M., Martelli, M. F., Moretta, L. and Ciccone, E., Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J. Immunol. 1989. 143: 2480-2488.
14. Parker, C. M., Groh, V., Band, H., Porcelli, S. A., Morita, C., Fabbi, M., Glass, D., Strominger, J. L. and Brenner, M. B., Evidence for extrathymic changes in the T cell receptor γδ repertoire. J. Exp. Med. 1990. 171: 1597-1612.
15. De Libero, G., Sentinel function of broadly reactive human γδ T cells. Immunol. Today 1997. 18: 22-26.
16. Hayday, A. C., γδ cells: A right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 2000. 18: 975-1026.
17. + T cells during mycobacterial infections. Science 2002. 295: 2255-2258.
18. Morita, C. T., Mariuzza, R. A. and Brenner, M. B., Antigen recognition by human γδ T cells: Pattern recognition by the adaptive immune system. Springer Semin. Immunopathol. 2000. 22: 191-217.
19. Rust, C. J., Verreck, F., Vietor, H. and Koning, F., Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the Vγ9 region. Nature 1990. 346: 572-574.
20. Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L. and Baldari, C. T., Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases. FASEB J. 2005. 19: 605-607.
21. Dunn, S. E., Youssef, S., Goldstein, M. J., Prod'homme, T., Weber, M. S., Zamvil, S. S. and Steinman, L., Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J. Exp. Med. 2006. 203: 401-412.
22. Ghittoni, R., Napolitani, G., Benati, D., Ulivieri, C., Patrussi, L., Laghi Pasini, F., Lanzavecchia, A. and Baldari, C. T., Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. Eur. J. Immunol. 2006. 36: 2885-2893.
23. Omkumar, R. V., Darnay, B. G. and Rodwell, V. W., Modulation of Syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase activity by phosphorylation. Role of serine 871. J. Biol. Chem. 1994. 269: 6810-6814.
24. Istvan, E. S. and Deisenhofer, J., The structure of the catalytic portion of human HMG-CoA reductase. Biochim. Biophys. Acta 2000. 1529: 9-18.
25. Wera, S. and Hemmings, B. A., Serine/threonine protein phosphatases. Biochem. J. 1995. 311 (Pt 1): 17-29.
26. Favre, B., Turowski, P. and Hemmings, B. A., Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem. 1997. 272: 13856-13863.
27. Sosroseno, W., Bird, P. S. and Seymour, G. J., Intracellular proteins involved in Porphyromonas gingivalis-induced opsonophagocytic activities of a murine macrophage cell line (RAW264.7 cells). J. Microbiol. Immunol. Infect. 2003. 36: 229-235.
28. Zhang, P., Nelson, S., Summer, W. R. and Spitzer, J. A., Serine/ threonine phosphorylation in cellular signaling for alveolar macrophage phagocytic response to endotoxin. Shock 2000. 13: 34-40.
29. Fisch, P., Malkovsky, M., Kovats, S., Sturm, E., Braakman, E., Klein, B. S., Voss, S. D. et al., Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 1990. 250: 1269-1273.
30. Gerber, R., Ryan, J. D. and Clark, D. S., Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS. Anal. Biochem. 2004. 329: 28-34.
31. Holtmeier, W. and Kabelitz, D., gammadelta T cells link innate and adaptive immune responses. Chem. Immunol. Allergy 2005. 86: 151-183.
32. + T cells and anti-microbial immune responses. Microbes Infect. 2003. 5: 491-498.
33. Dunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H. and Rogers, M. J., Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J. Pharmacol. Exp. Ther. 2001. 296: 235-242.
34. Istvan, E. S. and Deisenhofer, J., Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001. 292: 1160-1164.
35. Scotet, E., Martinez, L. O., Grant, E., Barbaras, R., Jeno, P., Guiraud, M., Monsarrat, B. et al., Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 2005. 22: 71-80.
36. Goldstein, J. L. and Brown, M. S., Regulation of the mevalonate pathway. Nature 1990. 343: 425-430.
37. Demoulin, J. B., Ericsson, J., Kallin, A., Rorsman, C., Ronnstrand, L. and Heldin, C. H., Platelet-derived growth factor stimulates membrane lipid synthesis through activation of phosphatidylinositol 3-kinase and sterol regulatory element-binding proteins. J. Biol. Chem. 2004. 279: 35392-35402.
38. Nadeau, K. J., Leitner, J. W., Gurerich, I. and Draznin, B., Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes. J. Biol. Chem. 2004. 279: 34380-34387.
39. Lee, J. N. and Ye, J., Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 2004. 279: 45257-45265.
40. Castoreno, A. B., Wang, Y., Stockinger,W., Jarzylo, L. A., Du, H., Pagnon, J. C., Shieh, E. C. and Nohturfft, A., Transcriptional regulation of phagocytosis-induced membrane biogenesis by sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA 2005. 102: 13129-13134.
41. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. and van der Goot, F. G., Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006. 126: 1135-1145.
42. Seong, S. Y. and Matzinger, P., Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004. 4: 469-478.
43. Grundy, S. M., HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N. Engl. J. Med. 1988. 319: 24-33.
44. Greenwood, J., Steinman, L. and Zamvil, S. S., Statin therapy and autoimmune disease: From protein prenylation to immunomodulation. Nat. Rev. Immunol. 2006. 6: 358-370.
45. Gilleron, M., Stenger, S., Mazorra, Z., Wittke, F., Mariotti, S., Bohmer, G., Prandi, J. et al., Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 2004. 199: 649-659.
46. De Libero, G., Casorati, G., Giachino, C., Carbonara, C., Migone, N., Matzinger, P. and Lanzavecchia, A., Selection by two powerful antigens may account for the presence of the major population of human peripheral γδ T cells. J. Exp. Med. 1991. 173: 1311-1322.
47. Shamshiev, A., Donda, A., Carena, I., Mori, L., Kappos, I., and De Libero, G., Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 1999. 29: 1667-1675.
48. Nowbakht, P., Ionescu, M. C., Rohner, A., Kalberer, C. P., Rossy, E., Mori, L., Cosman, D. et al., Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood 2005. 105: 3615-3622.
49. Park, E. J., Lee, D., Shin, Y. G., Lantvit, D. D., van Breemen, R. B., Kinghorn, A. D. and Pezzuto, J. M., Analysis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 2001. 754: 327-332.
50. Biardi, L., Sreedhar, A., Zokaei, A., Vartak, N. B., Bozeat, R. L., Shackelford, J. E., Keller, G. A. and Krisans, S. K., Mevalonate kinase is predominantly localized in peroxisomes and is defective in patients with peroxisome deficiency disorders. J. Biol. Chem. 1994. 269: 1197-1205.